Promoter Hypermethylation of Wnt/β-catenin Signaling Pathway Inhibitor WIF-1 Gene and its Association with MTHFR C677T Polymorphism in Patients with Colorectal Cancer
Open Access
- 15 May 2020
- journal article
- Published by Oman Medical Journal in Oman Medical Journal
- Vol. 35 (3), e131
- https://doi.org/10.5001/omj.2020.49
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Cancer Incidence in Oman (1996–2015)Oman Medical Journal, 2019
- Targeting the Wnt/beta-catenin pathway in cancer: Update on effectors and inhibitorsCancer Treatment Reviews, 2017
- Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012International Journal of Cancer, 2014
- Downregulation of WIF-1 and Wnt5a in patients with colorectal carcinoma: clinical significanceTumor Biology, 2014
- Impact of chromosomal instability on colorectal cancer progression and outcomeBMC Cancer, 2014
- Molecular mechanisms underlying the potentially adverse effects of folatecclm, 2013
- Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's RoleAdvances in Nutrition: An International Review Journal, 2012
- Five common cancers in Iran.2010
- Wnt Inhibitory Factor 1 Decreases Tumorigenesis and Metastasis in OsteosarcomaMolecular Cancer Therapeutics, 2010
- Genomic and Epigenetic Instability in Colorectal Cancer PathogenesisGastroenterology, 2008